Coutts Europe ex UK ESG Insights Equity Fund C EUR DistRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | 15.5 | -8.3 | 16.3 | 4.3 | |
+/-Cat | - | 0.1 | 0.5 | 2.8 | 1.8 | |
+/-B’mrk | - | -1.7 | -0.8 | 1.3 | -0.2 | |
Category: Europe ex-UK Equity | ||||||
Category Benchmark: Morningstar DM Eur xUK TME ... |
Key Stats | ||
NAV 20/11/2024 | EUR 12.63 | |
Day Change | -0.64% | |
Morningstar Category™ | Europe ex-UK Equity | |
ISIN | IE00BN782Q71 | |
Fund Size (Mil) - | - | |
Share Class Size (Mil) 30/09/2024 | EUR 13.29 | |
Max Initial Charge | - | |
Ongoing Charge 25/06/2024 | 0.08% |
Investment Objective: Coutts Europe ex UK ESG Insights Equity Fund C EUR Dist |
The investment objective of the fund is to provide a total return, taking into account both capital and income returns, while seeking to maximise the opportunities and minimise the potential risks associated with certain ESG themes and considerations. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
- - | ||
Inception Date 18/11/2020 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe Ex UK NR EUR | Morningstar DM Eur xUK TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Coutts Europe ex UK ESG Insights Equity Fund C EUR Dist | 31/10/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk AS Class B | Healthcare | 4.36 |
Nestle SA | Consumer Defensive | 4.28 |
Novartis AG Registered Shares | Healthcare | 3.87 |
SAP SE | Technology | 3.58 |
ASML Holding NV | Technology | 3.32 |
Increase Decrease New since last portfolio | ||
Coutts Europe ex UK ESG Insights Equity Fund C EUR Dist |